期刊文献+

药品安全与风险管理 被引量:44

Drug Safety and Drug Risk Management
原文传递
导出
摘要 目的:保障用药安全,降低用药风险。方法:根据风险管理的基本原理,借鉴欧美实践,对药品风险管理的内容、药品安全与药品风险的关系和药品风险因素的类型等进行分析,并提出建议。结果与结论:引入风险管理可促进我国药品全过程安全管理的规范化与标准化,最大化药品的收益,最小化药品的风险。 OBJECTIVE: To ensure drug use safety and lower druginduced risks. METHODS: Based on risk management theory and USA-EU drug risk management system, we analyzed the contents of drug risk management, the relationship between drug safety and drug risk, and the classification of drug - risk factors etc. And some suggestions were put forward. RESULT & CONCLUSION: The introduction of drug - risk management system can help facilitate the normalization and standardization of drug safety control, maximize drug benefit and minimize drug risk.
出处 《中国药房》 CAS CSCD 北大核心 2007年第22期1687-1690,共4页 China Pharmacy
关键词 风险管理 药品安全 药品风险因素 收益 Risk management Drug safety Drug risk factor Profits
  • 相关文献

参考文献3

  • 1竟永华,郭剑非,李行.美国药品风险管理指南与案例分析[J].中国药物警戒,2005,2(4):193-196. 被引量:15
  • 2Gary CM,Colleen H.FDA Watch risk minimization initiative[J].Contract Pharma,2005,5(1):16.
  • 3European Medicines Agency.Guideline on Risk Management Systems for Medicinal Products for Human USE[EB/OL].http://www.em-ea.europa.eu.2005,12,12.2006,10,2.

二级参考文献12

  • 1[1]Waxman,Henry A.The Lessom of Vioxx-Drug Safety and Sales[J].N Engl J Med 2005 352:2576-2578.
  • 2[2]FDA Issues Final Risk Minimization Guidances[EB/OL].http://www.fda.gov/bbs/topics/news/2005/NEW01169.html,2005-07-20.
  • 3[3]Premarketing Risk Assessment[EB/OL].http://www.fda.gov/cder/guidance/6357fnl.htm,2005-07-20.
  • 4[4]Good Pharmacovigilance Practices and Pharmacoepidemiologic As-sessment[EB/OL].http://www.fda.gov/cder/guidance/6359OCC.htm,2005-07-20.
  • 5[5]Development and Use of Risk Minimization Action Plans[EB/OL].http://www.fda.gov/cder/guidance/6358fnl.htm,2005-07-20.
  • 6[6]FDA[EB/OL].http://www.fda.gov/bbs/topics/ANSWERS/ANS00843.html,2005-07-20.
  • 7[7]FDA[FB/OL].http://www.fda.gov/cder/drug/infopage/lotronexqa_0602.htm,2005-07-20.
  • 8[8]Prescribing Program for Lotronex[EB/OL].http://www.lotronex.com/approvalpopup.htm,2005-07-20.
  • 9[9]FDA Announces Enhancement to Isotretinoin Risk Management Program[EB/OL].http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01328.html,2005-07-20.
  • 10[11]European Risk Management Strategy:Progress to date and next steps[EB/OL].http://www.emea.eu.int/pdfs/human/phv/13625305en.pdf,2005-07-20.

共引文献14

同被引文献372

引证文献44

二级引证文献187

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部